Close
ACHEMA MIDDLE EAST 2026

Micromeritics Introduces Cloud-based MicroActive Share

AI Summary

Micromeritics has announced the release of MicroActive Share, a cloud-based infrastructure in its product portfolio.

The infrastructure provides a new platform for bringing together internal and external data, protected in a cloud environment for its academic customers, and frees users from only being able to access data from within the lab and enables simultaneous use by unlimited members.

The software allows users to interactively evaluate adsorption data from Micromeritics ASAP and 3 FLEX gas adsorption instruments.

Users can include or exclude data, fitting the desired range of experimentally acquired data points using interactive, movable calculation bars.

One-click access to important parameters allows users to focus on the result rather than the parameters.

MicroActive Share is fully integrated with MicroActive Interactive Data Analysis Software, which will save customers time and create a flexible work environment.

Micromeritics president Preston Hendrix said: “In the 53 years that Micromeritics has been designing and building particle characterisation products we have received much guidance from students, researchers and scientists.

Our EDU Program and product line is designed to allow Micromeritics to give back to those that made our success possible.”

Key features of MicroActive Share include:

 

  • Analysis results anywhere, anytime with cloud-based access
  • Simultaneous use by unlimited members
  • Controlled data sharing with personalised preferences for people worldwide
  • Functionality of MicroActive Interactive Data Analysis Software
  • Worldwide research collaboration capability
  • MicroActive Share will be available for purchase in summer 2015.

Senior pharmaceutical decision - makers don’t consume every piece of content. They have sources they trust. Pharma Advancement is one of them.

Reaching this audience means appearing where they already are — inside trusted editorial that covers the full pharmaceutical and life sciences value chain. Our 2026 Media Pack shows you where to be seen:

Magazine & Digital

Where pharmaceutical decision - makers go to understand what’s coming next. Your brand belongs in that conversation.

Insights & Reports

The analysis and research the sector references when it matters most. Being part of it positions you differently.

Brand Authority

The companies that show up consistently in trusted editorial don’t need to explain who they are. They already are.

SUBSCRIBE OUR NEWSLETTER

WHITE PAPERS

RELATED ARTICLES